FILE PHOTO: AstraZeneca's logo is reflected in a drop on a syringe needle in this illustration taken November 9, 2020. REUTERS/Dado Ruvic/Illustration/File Photo
(Reuters) - Europe's medicines regulator on Friday approved AstraZeneca and Oxford University's COVID-19 vaccine for people over the age of 18, the third vaccine to be cleared for use in the European Union.
The AstraZeneca vaccine demonstrated an efficacy of around 60% in the trials on which the decision was based, the European Medicines Agency (EMA) said in a statement https://bit.ly/3pwGYlx.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
